Rossmax International Ltd (4121) - Net Assets

Latest as of December 2025: NT$1.98 Billion TWD ≈ $62.50 Million USD

Based on the latest financial reports, Rossmax International Ltd (4121) has net assets worth NT$1.98 Billion TWD (≈ $62.50 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$4.21 Billion ≈ $132.58 Million USD) and total liabilities (NT$2.22 Billion ≈ $70.08 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible net worth ratio of Rossmax International Ltd to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets NT$1.98 Billion
% of Total Assets 47.14%
Annual Growth Rate 4.91%
5-Year Change 11.48%
10-Year Change N/A
Growth Volatility 9.58

Rossmax International Ltd - Net Assets Trend (2017–2025)

This chart illustrates how Rossmax International Ltd's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Rossmax International Ltd to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Rossmax International Ltd (2017–2025)

The table below shows the annual net assets of Rossmax International Ltd from 2017 to 2025. For live valuation and market cap data, see Rossmax International Ltd (4121) total market value.

Year Net Assets Change
2025-12-31 NT$1.98 Billion
≈ $62.50 Million
-5.02%
2024-12-31 NT$2.09 Billion
≈ $65.81 Million
+12.84%
2023-12-31 NT$1.85 Billion
≈ $58.32 Million
-4.80%
2022-12-31 NT$1.94 Billion
≈ $61.26 Million
+9.27%
2021-12-31 NT$1.78 Billion
≈ $56.06 Million
+7.20%
2020-12-31 NT$1.66 Billion
≈ $52.30 Million
+24.67%
2019-12-31 NT$1.33 Billion
≈ $41.95 Million
-0.72%
2018-12-31 NT$1.34 Billion
≈ $42.25 Million
-0.84%
2017-12-31 NT$1.35 Billion
≈ $42.61 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Rossmax International Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 13.8% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings NT$313.56 Million 22.24%
Other Components NT$1.10 Billion 77.76%
Total Equity NT$1.41 Billion 100.00%

Rossmax International Ltd Competitors by Market Cap

The table below lists competitors of Rossmax International Ltd ranked by their market capitalization.

Company Market Cap
Wiseway Group Ltd
AU:WWG
$35.33 Million
Sol Strategies Inc. Common Shares
NASDAQ:STKE
$35.35 Million
Osangjaiel Co. Ltd
KQ:053980
$35.36 Million
Manx Financial Group PLC
F:3IM
$35.36 Million
Sunstone Metals Ltd
AU:STM
$35.32 Million
Halcyon Technology Public Company Limited
BK:HTECH
$35.30 Million
Heimstaden AB Pfd.
ST:HEIM-PREF
$35.30 Million
New Palace International Co Ltd
TW:8940
$35.30 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Rossmax International Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 1,482,968,000 to 1,410,134,000, a change of -72,834,000 (-4.9%).
  • Net loss of 29,897,000 reduced equity.
  • Share repurchases of 42,417,000 reduced equity.
  • New share issuances of 1,056,000 increased equity.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income NT$-29.90 Million -2.12%
Share Repurchases NT$42.42 Million -3.01%
Share Issuances NT$1.06 Million +0.07%
Other Changes NT$-1.58 Million -0.11%
Total Change NT$- -4.91%

Book Value vs Market Value Analysis

This analysis compares Rossmax International Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.80x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 NT$15.39 NT$13.55 x
2018-12-31 NT$15.19 NT$13.55 x
2019-12-31 NT$15.16 NT$13.55 x
2020-12-31 NT$18.13 NT$13.55 x
2021-12-31 NT$17.03 NT$13.55 x
2022-12-31 NT$18.21 NT$13.55 x
2023-12-31 NT$17.00 NT$13.55 x
2024-12-31 NT$17.36 NT$13.55 x
2025-12-31 NT$17.04 NT$13.55 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Rossmax International Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -2.12%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -0.79%
  • • Asset Turnover: 0.90x
  • • Equity Multiplier: 2.98x
  • Recent ROE (-2.12%) is below the historical average (3.38%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2017 2.43% 0.88% 1.31x 2.12x NT$-86.01 Million
2018 1.48% 0.54% 1.35x 2.05x NT$-95.56 Million
2019 2.30% 0.83% 1.01x 2.74x NT$-86.20 Million
2020 10.10% 3.68% 1.10x 2.50x NT$1.33 Million
2021 7.70% 2.82% 1.05x 2.60x NT$-33.19 Million
2022 10.97% 3.92% 1.09x 2.57x NT$15.00 Million
2023 -0.46% -0.17% 0.93x 2.83x NT$-151.04 Million
2024 -1.98% -0.76% 0.91x 2.85x NT$-177.64 Million
2025 -2.12% -0.79% 0.90x 2.98x NT$-170.91 Million

Industry Comparison

This section compares Rossmax International Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $2,161,665,222
  • Average return on equity (ROE) among peers: 16.66%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Rossmax International Ltd (4121) NT$1.98 Billion 2.43% 1.12x $35.33 Million
Hi-Clearance (1788) $2.30 Billion 15.13% 0.93x $183.75 Million
Radiant Innovation (3373) $1.35 Billion 54.68% 0.43x $25.20 Million
Wellell Inc (4106) $1.28 Billion 16.57% 0.29x $74.39 Million
United Orthopedic (4129) $2.93 Billion 3.02% 0.79x $276.18 Million
Dynamic Medical Technologies (4138) $1.43 Billion 7.33% 0.41x $65.17 Million
Ok Biotech Co Ltd (4155) $2.40 Billion 0.12% 0.28x $68.03 Million
Bioptik Technology (4161) $717.83 Million 6.76% 1.11x $43.53 Million
AViTA Corporation (4735) $422.85 Million 23.37% 1.55x $37.55 Million
TAIDOC TECHNOLOGY CORP (4736) $6.62 Billion 22.98% 0.38x $373.31 Million

About Rossmax International Ltd

TWO:4121 Taiwan Medical Devices
Market Cap
$35.33 Million
NT$1.12 Billion TWD
Market Cap Rank
#23261 Global
#1464 in Taiwan
Share Price
NT$13.55
Change (1 day)
-0.37%
52-Week Range
NT$13.45 - NT$20.40
All Time High
NT$34.59
About

Rossmax International Ltd. develops and supplies healthcare products and solutions. The company offers body fat monitors and scales that are used to measure body fat, body mass index, lean mass, muscle mass, and water ratio along with body weight; blood pressure monitors; sphygmomanometer, a device that measures blood pressure; stethoscope, an acoustic medical device for auscultation, or listenin… Read more